|
|
||||||||
1 School of Exercise and Sport Science, Faculty of Health Sciences, University of Sydney, Lidcombe, New South Wales 2141; 2 Department of Physiology, Australian Institute of Sport, Canberra, Australian Capital Territory 2616; 3 Exercise Metabolism Group, School of Medical Science, Royal Melbourne Institute of Technology University, Bundoora, Victoria 3083; and 4 School of Human Movement, Recreation, and Performance, Centre for Rehabilitation, Exercise, and Sports Sciences, Victoria University of Technology, Melbourne, Victoria 8001, Australia
| |
ABSTRACT |
|---|
|
|
|---|
This study determined whether
"living high-training low" (LHTL)-simulated altitude exposure
increased the hypoxic ventilatory response (HVR) in well-trained
endurance athletes. Thirty-three cyclists/triathletes were divided into
three groups: 20 consecutive nights of hypoxic exposure (LHTLc,
n = 12), 20 nights of intermittent hypoxic exposure
(four 5-night blocks of hypoxia, each interspersed with 2 nights of
normoxia, LHTLi, n = 10), or control (Con,
n = 11). LHTLc and LHTLi slept 8-10 h/day
overnight in normobaric hypoxia (~2,650 m); Con slept under ambient
conditions (600 m). Resting, isocapnic HVR
(
E/
SpO2, where
E is minute ventilation and
SpO2 is blood O2 saturation) was
measured in normoxia before hypoxia (Pre), after 1, 3, 10, and 15 nights of exposure (N1, N3, N10, and N15, respectively), and 2 nights
after the exposure night 20 (Post). Before each HVR test,
end-tidal PCO2
(PETCO2) and
E were
measured during room air breathing at rest. HVR
(l · min
1 · %
1)
was higher (P < 0.05) in LHTLc than in Con at N1
(0.56 ± 0.32 vs. 0.28 ± 0.16), N3 (0.69 ± 0.30 vs.
0.36 ± 0.24), N10 (0.79 ± 0.36 vs. 0.34 ± 0.14), N15
(1.00 ± 0.38 vs. 0.36 ± 0.23), and Post (0.79 ± 0.37 vs. 0.36 ± 0.26). HVR at N15 was higher (P < 0.05) in LHTLi (0.67 ± 0.33) than in Con and in LHTLc than in LHTLi. PETCO2 was depressed in LHTLc and
LHTLi compared with Con at all points after hypoxia
(P < 0.05). No significant differences were observed
for
E at any point. We conclude that LHTL increases HVR in endurance athletes in a time-dependent manner and decreases PETCO2 in normoxia, without change in
E. Thus endurance athletes sleeping in mild hypoxia
may experience changes to the respiratory control system.
altitude training; chemoresponsiveness; cyclists; triathletes; ventilatory acclimatization
| |
INTRODUCTION |
|---|
|
|
|---|
VENTILATORY
ACCLIMATIZATION is defined as "a time-dependent change in
ventilatory magnitude resulting from exposure to a changed environment" (7). On acute exposure to hypoxia, one of
the earliest and most consistent physiological responses is an increase in minute ventilation (
E), mediated primarily by
hypoxic stimulation of the peripheral chemoreceptors (7).
Ventilatory acclimatization to chronic hypoxic exposure, however,
displays a triphasic response. The initial, rapid increase in
E is followed by ventilatory depression after
20-30 min of hypoxia (8), and then over a period of
hours to days, there is a gradual and progressive, time-dependent increase in
E (1, 9, 20).
Ventilatory acclimatization to altitude is facilitated by increased
sensitivity of the peripheral chemoreceptors to hypoxia, estimated by
the hypoxic ventilatory response (HVR) in humans (3). The
HVR has been reported to correlate with the magnitude of increase in
E on arrival at altitude (19), and
several studies have demonstrated an increase in the HVR during natural altitude acclimatization (31, 33, 39) or intermittent
hypoxic exposure (11, 21). An enhancement of the HVR
during acclimatization is viewed as a positive adaptation, because an
increase in
E improves alveolar O2
pressure and raises arterial oxygenation while at altitude
(19). An increase in the HVR allows ventilatory acclimatization to altitude to proceed, despite an inhibitory influence
of respiratory alkalosis (7) and a decrease in the original hypoxic stimulus.
In contrast to altitude acclimatization, endurance training appears to decrease the HVR. Endurance-trained athletes demonstrate a blunted HVR compared with untrained, healthy individuals (4, 34), and a decrease in the HVR has been observed after endurance training in previously untrained subjects (22). Furthermore, when endurance training was conducted during 1 wk of an intermittent hypoxic exposure protocol (30 min/day, 4,500-m simulated altitude) that did increase the HVR in nontraining control subjects, no change in the HVR was reported (21). Therefore, endurance training and adaptation to hypoxia appear to have opposing effects on the HVR.
Altitude training is commonly used by athletes for specific competition preparation or to provide an alternative physiological stress at some other point in the training macrocycle. Additionally, discontinuous hypoxic exposure in the form of "living high-training low" (LHTL) is a popular practice among athletes because this strategy allows exposure to hypoxia with concurrent maintenance of training intensity at or near sea level (14). The time course of ventilatory acclimatization to altitude is well documented in healthy, untrained individuals (3, 7), but the effect of discontinuous hypoxic exposure on ventilatory acclimatization in well-trained endurance athletes has received little attention. In this study, we hypothesized that athletes undergoing LHTL at a simulated altitude of 2,650 m while training at 600 m would exhibit ventilatory acclimatization and an augmented HVR. Previous observations have indicated that not all athletes respond to the hypoxic stimulus of altitude in a uniform manner (5); therefore, we also hypothesized that athletes would exhibit substantial individual variation in ventilatory acclimatization and enhancement of the HVR in response to LHTL. Finally, it has been suggested that individual differences in ventilatory acclimatization to altitude could be the result of differences in the preexisting HVR (29), which is known to vary markedly between individuals (16). Consequently, we hypothesized that athletes with a higher HVR would demonstrate a greater degree of ventilatory acclimatization during the early stages of LHTL.
| |
METHODS |
|---|
|
|
|---|
Subjects.
Thirty-three male endurance-trained athletes (9 triathletes and 24 cyclists) gave written informed consent to participate in the study,
which was approved by the Australian Institute of Sport Ethics
Committee. Subjects were divided into three groups matched for initial
maximal O2 consumption. It was not possible to initially
randomize all subjects into the three groups, because the altitude
house could accommodate only eight people at any one time. Accordingly,
the experimental design necessitated four independent waves of testing
to study 33 subjects. The three groups comprised an LHTL consecutive
(LHTLc) group (n = 12), an LHTL intermittent (LHTLi)
group (n = 10), and a control (Con) group (n = 11). Normal lung function (13) was
verified in all subjects using a spirometer (model AS600, Minato
Medical Science, Osaka, Japan). Subject characteristics for each group
are presented in Table 1.
|
1 wk
before and continuing throughout the experimental period.
Overview of experimental design. The LHTLc group spent 8-10 h/day for 20 consecutive nights in a room enriched with N2, simulating an altitude of 2,650 m in normobaric hypoxia (16.3% inspired O2, ~710 Torr ambient barometric pressure). The LHTLi group also spent a total of 20 nights sleeping in hypoxia at a simulated altitude of 2,650 m, comprising 4 "blocks" of 5 nights in hypoxia, with each block interspersed by 2 nights of sleep in normoxia at a natural altitude of 600 m (Canberra, Australia). Details of the altitude house operation have been described in detail previously (2). The Con group slept in dormitory-style accommodation under Canberra ambient conditions during the entire experimental protocol. Daytime hours were spent in ambient conditions.
Each subject completed a baseline resting HVR test (Pre) within 2 wk before hypoxic exposure, with the HVR remeasured on the morning after 1 (N1), 3 (N3), 10 (N10), and 15 (N15) nights of hypoxia. A final measurement was taken 2 days after the 20th night of hypoxia (Post). Baseline HVR measures were repeated in 24 subjects to determine the typical error of measurement (TEM) for the HVR (18).HVR.
The HVR was determined using a modification of the method of Weil et
al. (38), with all tests conducted in a fasted state, in
normobaric normoxia, within 2 h of waking. No alcohol or caffeine was consumed for 12 h preceding an HVR test. Immediately before the test, subjects rested in a chair for 10 min. Throughout the test,
subjects were given reading material and listened to quiet music to
minimize behavioral influences on resting breathing patterns. At the
start of the test, subjects breathed room air for 5 min through a
two-way respiratory valve (model R2700, Hans Rudolph, Kansas City, MO)
while wearing a nose clip, and
E was measured using
a 0-100 l/min heated pneumotachometer (model 3719, Hans Rudolph)
coupled to a proprietary pneumotach system (model RSS 100HR, Hans
Rudolph). The pneumotachometer was calibrated before every test with a
1-liter volumetric syringe. Expired O2 and CO2 were sampled continuously from a mouth port and measured using an
Ametek S-3A O2 analyzer and CD-3A CO2 analyzer,
respectively (Applied Electrochemistry, Pittsburgh, PA). Immediately
before each test, gas analyzers were calibrated with three
precision-grade gases (BOC Gases, Sydney, Australia) containing 18.16, 14.51, and 8.96% O2 and 5.50, 2.49, and 0.00%
CO2, respectively. Heart rate (HR) and blood O2
saturation (SpO2) were estimated by finger-tip pulse oximetry (model 505-US, Criticare Systems, Waukesha, WI). Analog
output signals from the pneumotach system, the gas analyzers, and the
pulse oximeter were sampled at 50 Hz and time synchronized using custom
data acquisition software.
HVR data analysis.
To allow time for stable resting ventilatory patterns to be achieved,
only the last 60 s of room air breathing were used for calculation
of the HVR, resting
E, and
PETCO2. Ventilatory data were initially
expressed as individual breath-by-breath values. The average
SpO2 during each breath was calculated, and
end-tidal PO2
(PETO2) and
PETCO2 were determined for each breath. In
cases of ventilatory instability (e.g., swallowing and coughing) where abnormal
E values were observed, three successive
breaths were averaged. All data points were then smoothed using a
rolling average with an interval of five breaths. Linear regression was
conducted on the
E-SpO2
relationship, and the slope of the line (HVRlin, l · min
1 · %
1)
was calculated. A least squares curve fit was applied to the
E-PETO2 relationship
using Prism software (GraphPad Software, San Diego, CA) according to
the following hyperbolic equation
|
E when
PETO2 is low. For the constant
B, a value of 26 Torr, instead of 32 Torr as originally described by Weil et al. (38), was chosen, because our
criteria for termination of the HVR test allowed
PETO2 to consistently fall 5-6 Torr
below that of Weil et al., who used 40 Torr as their termination
criterion. The use of 26 Torr, rather than 32 Torr, for the constant
B was found to be justified, since on numerous occasions
PETO2 values fell below 32 Torr toward the
end of the HVR test. In these cases, using 32 Torr as the nadir for
PETO2 resulted in a negative value for
parameter A and a poor curve fit (r < 0.05). A mean r of 0.88 across all trials was found for the
hyperbolic curve fit relating
e and
PETO2 when B was 26 Torr.
Ventilatory acclimatization.
The change in resting PETCO2
(
PETCO2) from Pre to N1, N3, N10, and
N15 was determined for each subject and used as an index of ventilatory
acclimatization (29).
Statistical analysis.
Values are means ± SD. Each dependent variable was analyzed using
a two-way analysis of variance (ANOVA) with repeated measures over time
(group × day). For subjects who completed dual baseline HVR
measures, only results from the second test were included in the
two-way ANOVA. Significant main effects and interactions were
subsequently analyzed using Tukey's honestly significant difference
post hoc procedure. To examine the specific effect of return to
normoxia on the HVR, data were pooled for LHTLc and LHTLi, and N15 was
compared with Post using a paired t-test. This procedure was
considered appropriate, because both groups were exposed to the hypoxic
stimulus and the pooling maximized statistical power. For each subject,
HVRlin and HVRhyp were each plotted against time, from Pre to N15, and linear regression was performed on the
relationship to produce an "HVR slope." Therefore, units for the
linear response slope are change in the HVR (expressed as l · min
1 · %
1
for HVRlin or parameter A for
HVRhyp) per day (
HVR/day). Differences in the mean
response slope between groups were examined with a one-way ANOVA, as
were differences in mean training volume (h/wk). The within-group SD
for the response slope was compared between LHTLc and Con and between
LHTLi and Con using a t-test for independent samples.
Individual responders vs. nonresponders were determined by significant
deviation of the HVR slope from zero using a standard F
test. Strong responders were defined as those subjects whose response
slopes were greater than zero (P < 0.05) for
HVRlin and HVRhyp variables. Moderate
responders were defined as those subjects whose response slopes were
greater than zero (P < 0.05) for HVRlin or
HVRhyp or were greater than zero (P < 0.1)
for both variables. Nonresponders were defined as subjects whose
response slopes for HVRlin and HVRhyp variables
were not significantly (P > 0.1) different from zero.
Relationships between variables were examined using linear regression.
Statistical significance was accepted at P < 0.05, and
all analyses were completed using Statistica software version 5.0 (StatSoft, Tulsa, OK).
HVR typical error and internal validity.
The within-subject SD, also called TEM, was determined from the dual
baseline values for HVRlin and HVRhyp
variables, resting
E, and
PETCO2. Additionally, linear regression
was conducted on the relationship between HVRlin and
HVRhyp for each time point during the experimental protocol.
Treatment of outliers.
In 3 of the 222 HVR tests conducted (1 occasion each in 3 subjects),
HVRlin values were above the group upper quartile by >1.5
times the interquartile range of the group. These scores were defined
as outliers according to standard statistical procedure (36), and on each occasion, SpO2
did not fall below 85% when PETO2 values
were as low as 40 Torr, thereby failing to meet the test termination
criteria. In each case, HVRlin appeared to be greatly
exaggerated, despite HVRhyp values within the acceptable range. The error in these three tests was most likely due to technical error in the measurement of SpO2. Accordingly,
data for two tests conducted at N15 and one at N3 were corrected by
fitting a fourth-order polynomial to the
SpO2-PETO2 curve
obtained from their tests recorded at N10 and N1, respectively. The
PETO2 values recorded during the outlier
tests were then used to estimate the SpO2
values, and the HVRlin slope was recalculated using these
corrected SpO2 values. One test recorded at N3
yielded a raw value of 2.14 l · min
1 · %
1
and was corrected to 0.91 l · min
1 · %
1,
and two tests recorded at N15 yielded raw values of 3.52 and 3.17 l · min
1 · %
1
and were corrected to 1.23 and 1.28 l · min
1 · %
1, respectively.
| |
RESULTS |
|---|
|
|
|---|
HVRlin.
The mean HVRlin values at Pre were not significantly
different between groups (Fig.
1A), indicating similar
baseline hypoxic chemosensitivity in all groups. However, there was a
significant group × day interaction (P < 0.001).
In LHTLc, the HVRlin was increased above Pre at N3, N10,
N15, and Post (P < 0.05) and greater than Con at N1, N3,
N10, N15, and Post (P < 0.05). Additionally, HVRlin was greater in LHTLc than in LHTLi at N15
(P < 0.05). In contrast, for LHTLi, HVRlin
was increased above Pre only at N15, where it was also greater than Con
(P < 0.05). For pooled LHTLc and LHTLi data,
HVRlin was lower (P = 0.04) at Post than at
N15 (0.68 ± 0.40 vs. 0.85 ± 0.39 l · min
1 · %
1).
|
HVRhyp. There was a significant group × day interaction (P < 0.001) for HVRhyp (Fig. 1B). Post hoc analysis revealed no significant difference between groups at Pre, but in LHTLc, HVRhyp was elevated above Pre and was greater than Con at N10, N15, and Post (P < 0.05). For LHTLi, HVRhyp was greater than Pre and Con only at N15 (P < 0.05). For pooled LHTLc and LHTLi data, HVRhyp was lower (P = 0.004) at Post than at N15 (203 ± 99 vs. 294 ± 142 parameter A units).
Correlation between HVRlin and HVRhyp. The correlation between HVRlin and HVRhyp was significant at all time points (0.70 < r < 0.90, P < 0.001).
HVR slope.
The group main effect for the HVR slope was significant for
HVRlin (P < 0.001) and HVRhyp
(P < 0.001). The mean HVRlin slope was
greater in LHTLc than in LHTLi and Con [0.047 ± 0.039 vs. 0.016 ± 0.014 (P < 0.05) and 0.0028 ± 0.0079
HVR/day (P < 0.05)]. For the
HVRhyp variable, the mean response slopes for LHTLc and LHTLi (11.21 ± 6.55 and 7.75 ± 6.04
HVR/day,
respectively) were greater than for Con (0.63 ± 3.12
HVR/day,
P < 0.05). However, LHTLc was not significantly
different from LHTLi.
Responders vs. nonresponders.
The SD of the HVRlin slopes was greater for LHTLc than for
Con (SD = 0.019 vs. 0.008
HVR/day, P = 0.01).
The SD of the HVRlin slopes tended to be greater for LHTLi
(SD = 0.014) than for Con; however, the difference was not
significant (P = 0.08). Similar results were obtained
for the HVRhyp slope [SD = 6.35
HVR/day for LHTLc,
3.12
HVR/day for Con (P = 0.03), and 6.04
HVR/day for LHTLi (P = 0.051)]. Seven subjects responded
strongly to the experimental treatment, seven responded moderately, and
eight did not respond (Fig. 2). For the
LHTLc group, 5 of 12 subjects were strong responders, 4 were moderate
responders, and 3 were nonresponders. For the LHTLi group, 2 of 10 subjects were strong responders, 3 were moderate responders, and 5 were
nonresponders. One subject in the Con group displayed a significant
response; however, the magnitude of his response was lower than that of any subject defined as a responder in either treatment group. Additionally, a significant correlation between the
HVRhyp and the HVRlin slope (LHTLc and LHTLi
subjects only) was observed (r = 0.84, P < 0.001).
|
Resting PETCO2 and
E.
A significant group × day interaction (P < 0.001) was observed for resting PETCO2
(Fig. 3). Post hoc analysis did not
reveal a significant difference between groups at Pre. However, resting PETCO2 was lower in LHTLc and LHTLi than
Con at N1, N3, N10, N15, and Post (P < 0.05). Within
groups, PETCO2 was lower than Pre at N3
and N10 for LHTLc and LHTLi (P < 0.05). At N15 it was
lower than Pre in LHTLi (P < 0.05) and tended to be
lower in LHTLc (P = 0.07). No differences were observed
between or within groups over time for resting
E at
any point during the study.
|
Effect of HVR on ventilatory acclimatization.
When LHTLc and LHTLi data were pooled, the Pre HVRlin was
correlated (r =
0.44, P = 0.04) with
PETCO2 from Pre to N1 (Fig. 4A) and with
PETCO2 from Pre to N3
(r =
0.47, P = 0.03; Fig. 4B).
However, this relationship was not significant thereafter.
|
Training volume. Average training volume was higher in LHTLc than in Con (15.8 ± 3.7 vs. 11.0 ± 3.0 h/wk, P < 0.05), but neither differed significantly from LHTLi (13.3 ± 3.7 h/wk).
TEM of ventilatory measures.
The absolute TEM of the HVRlin method was 0.13 l · min
1 · %
1
or 35.4% of the mean (%TEM). The TEM of the HVRhyp method
was 51.8 parameter A units or 46.2% of the mean. The TEM of
resting
E was 1.24 l/min, and the TEM of resting
PETCO2 was 1.38 Torr, which were
equivalent to %TEM values of 16.7 and 3.6%, respectively.
| |
DISCUSSION |
|---|
|
|
|---|
The main findings of this study were that, in well-trained
endurance athletes, 1) the HVR increased during 20 nights of
LHTL exposure at a simulated altitude of 2,650 m, with the overall response being more pronounced during consecutive nightly exposure than
intermittent block exposure; 2) individual increases
in the HVR were variable, with stronger individual responses tending to
occur during consecutive nightly exposure; 3)
PETCO2 decreased progressively during the
first 3 nights of hypoxia, and this was related to the magnitude of the
Pre HVR; and 4) resting
E remained at
baseline levels, despite the decrease in
PETCO2.
Effect of LHTL on HVR.
In the present study, augmentation of the HVR was found for the linear
slope of the
E-SpO2
regression and parameter A in the treatment groups only.
Therefore, our results support the general consensus that hypoxic
exposure induces an increase in the HVR, as reported during natural
altitude acclimatization (10, 31, 32, 39), after
intermittent hypoxic exposure (11, 21, 25), or after
8 h of mild hypoxia (9). The increase in the HVR
observed in this study occurred despite previous findings that
short-term endurance training depresses the HVR (22, 23) and endurance-trained athletes display blunted hypoxic
chemoresponsiveness (4, 34). Furthermore, the HVR was
enhanced, even though the LHTLc group completed a greater weekly
training volume than the Con group.
1 · %
1)
and HVRhyp (117.4 ± 78.1 parameter A
units) values in our study were lower than those previously reported
for healthy, untrained individuals (16, 21, 38, 40).
However, our subjects also displayed high interindividual variability
of the HVR, as previously reported in healthy untrained individuals
(30). Therefore, despite the endurance-trained status of
our subjects, low hypoxic chemosensitivity does not appear to be a
uniform trait among this population.
Responders vs. nonresponders. Previous research indicates that all endurance athletes do not respond positively to LHTL (5). The variability of the HVR slopes was significantly greater in LHTLc and tended to be greater in LHTLi than in Con. This indicates that individual variation in the HVR due to endurance training alone is exacerbated by the addition of nightly hypoxic exposure. The greater incidence of strong responders in the LHTLc group provides additional support for the notion that consecutive nightly exposure is a greater stimulus to enhance the HVR than intermittent block-style exposure.
Ventilatory acclimatization to hypoxia.
PETCO2 has been described as "a
well-defined index of effective ventilation and acclimatization"
(29). In the present study, we found a decrease in
PETCO2 after 1 night (~8-10 h) at a
simulated altitude of 2,650 m, indicative of an increased
E during the overnight hypoxic exposure. Previous
studies have reported that PETCO2
decreases during acute altitude exposure and also declines progressively over several days to weeks (1, 19, 29).
Similar evidence of a progressive decrease in
PETCO2 during the first 3 nights of LHTL
was found in the present study, suggesting that repeated nightly
exposure to hypoxia induced hyperventilation, which had a cumulative
effect on depletion of CO2 body stores. PETCO2 was not further depressed at N10
than at N3; hence, ventilatory acclimatization to 2,650 m was probably
attained after 3 consecutive nights of exposure to hypoxia. However,
peak values for HVR were not obtained until after 15 nights of hypoxia.
The magnitude of depression in PETCO2 at
all points during LHTL was less than that reported for equivalent
periods of continuous altitude exposure at 4,300 m (1,
29), but in these studies, sea-level residents required ~10
days at altitude to achieve ventilatory acclimatization. Therefore,
ventilatory acclimatization to 2,650 m simulated altitude appeared to
have been achieved more rapidly than in nontraining subjects residing
at 4,300 m natural altitude, but the absolute magnitude of depression
in PETCO2 required to achieve ventilatory acclimatization was less in the present study. The effect of training per se on the time course of ventilatory acclimatization at a given
altitude remains to be elucidated.
PETCO2 after 1 and 3 nights of hypoxic
exposure. After 10 nights of exposure to hypoxia, even subjects with
low initial HVR scores displayed some depression of
PETCO2; hence, the correlation between Pre
HVRlin and
PETCO2 at N10
(and N15) was not significant. This suggests that the rate of
ventilatory acclimatization was more rapid in those subjects with
greater initial hypoxic chemosensitivity. Our results are consistent
with the findings of Huang et al. (19), who reported a
significant positive correlation between baseline HVR and resting
E after 4 days at 4,300 m, and Reeves et al.
(29), who reported a significant positive correlation
between sea-level HVR and arterial O2 saturation after 1 day at 4,300 m. In each of these studies, the magnitude of the
correlation was only moderate, but, collectively, the results indicate
that at least part of the variability in ventilatory acclimatization to
hypoxia is related to the magnitude of the preexisting HVR.
It is well known that hypocapnia attenuates the ventilatory response to
hypoxia (28, 38) and blunts the increase in resting
E on arrival at altitude (19). During
each HVR measurement, we maintained PETCO2
at the eucapnic level determined at the onset of each test, and since
PETCO2 for the LHTLc and LHTLi groups was
diminished during the experimental period, the true increase in HVR may
have been greater than observed. Interestingly, we found little change
in resting
E within 2 h of return to normoxia, suggesting that the depression of
PETCO2 was likely a result of ventilatory
acclimatization during overnight hypoxia leading to decreased
CO2 body stores, and not a short-term effect of elevated
E during the HVR test itself. Because resting
E in normoxia was not blunted, some
consequence of hypoxic exposure must have led to a stimulation of
E, such that the inhibitory effect of hypocapnia was
balanced out. At least two factors could have led to such an
effect: 1) increased sympathetic activation as a result of
hypoxic exposure, which has been shown to contribute to increased resting metabolic rate (27), which in turn contributes to
increased
E (20), and 2) a
change in the PCO2 set point of the respiratory control mechanism (6). A limitation of the present study
is that we did not assess sympathetic activation, nor did we measure basal metabolic rate or hypercapnic ventilatory response.
Methodological considerations.
We employed two distinct methods of analyzing data collected from the
HVR technique developed by Weil et al. (38): 1)
the linear relationship of 
E vs.
SpO2 (HVRlin) and 2)
the hyperbolic relationship of 
E vs.
PETCO2, the so called "shape
parameter A" (HVRhyp). The %TEM for the
HVRlin and HVRhyp variables was large
compared with measures such as maximal O2 uptake (l/min; TEM = 2.2%) or blood lactate at threshold (mmol/l; TEM = 13.3%) (12). Two studies that examined variability of the
HVR also reported relatively high coefficients of variation for
between-day comparisons, with values of 19.4% (30) and
36% (40). Hopkins (18) states that a
realistic threshold for assessing whether a real change has occurred is
nearly twice the TEM. In the present study, we observed an increase in
the mean HVRlin up to 4.3 times TEM in the LHTLc group and
2.1 times TEM in the LHTLi group. The mean HVRhyp was
increased by up to 3.6 and 2.4 times TEM in the LHTLc and LHTLi groups,
respectively. Therefore, despite the relatively high between-day
variance in the HVR, we were still able to detect significant
differences, since the increase in the HVR in the treatment groups and,
in particular, the LHTLc group was much greater than the imprecision of measurement.
E-SpO2 linear regression
line (15, 17, 19, 21-24, 29, 31, 32, 39). Few studies
have reported both (28, 35, 38), and no studies were
located that tracked changes in both variables over time. This study
was the first to investigate changes in linear slope and parameter
A during hypoxic acclimatization. The correlation between
parameter A and the slope of the
E-SpO2 regression line
reported by van Klaveren and Demedts (35) was r =
0.41. We found substantially higher correlation
coefficients of 0.71-0.89 over the course of the experiment (we
have presented the HVR slope by convention as a positive value;
therefore, the correlation between parameter A and linear
slope was positive). Additionally, a strong correlation
(r = 0.84) was observed between the HVRhyp
and HVRlin slopes. Therefore, the hyperbolic and linear methods of analysis display high internal validity and track changes in
the HVR over time within individuals, also with a high degree of
internal validity. We observed slightly different results between the
HVRlin and HVRhyp variables, but this result
was largely due to the presence of one atypical subject in the LHTLi
group who displayed high parameter A scores relative to the slope.
Conclusions.
This study provides strong evidence that well-trained endurance
athletes exhibit ventilatory acclimatization and an enhancement of the
HVR during consecutive nightly and intermittent block models of LHTL.
The results were consistent whether the HVR data were analyzed as a
linear function of the
E-SpO2 relationship or as a
hyperbolic function of the
E-PETCO2 relationship.
Consecutive nightly exposure to hypoxia was associated with a stronger
response than intermittent LHTL exposure. The preexisting HVR level
displayed high interindividual variability and was positively
correlated with the magnitude of ventilatory acclimatization during the
first 3 nights of hypoxic exposure. An important finding was that
resting
E remained unchanged on return to normoxia,
despite a decrease in PETCO2 after hypoxic
exposure. This suggests that as little as 1 night of mild hypoxic
exposure is sufficient to induce changes in the respiratory control system.
| |
ACKNOWLEDGEMENTS |
|---|
The authors acknowledge the support of BOC Gases Australia for supply of resources, equipment, and technical assistance; C. Mackintosh for software development and support; and R. Shugg and E. Lawton for technical assistance.
| |
FOOTNOTES |
|---|
This study was funded by Australian Research Council Grant C00002552.
Address for reprint requests and other correspondence: J. A. Hawley, Exercise Metabolism Group, RMIT University, PO Box 71, Bundoora, Victoria 3083, Australia (E-mail: john.hawley{at}rmit.edu.au).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
June 30, 2002;10.1152/japplphysiol.00381.2002
Received 2 May 2002; accepted in final form 20 June 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Asano, K,
Mazzeo RS,
McCullough RE,
Wolfel EE,
and
Reeves JT.
Relation of sympathetic activation to ventilation in man at 4,300 m altitude.
Aviat Space Environ Med
68:
104-110,
1997.
2.
Ashenden, MJ,
Gore CJ,
Dobson GP,
and
Hahn AG.
"Live high, train low" does not change the total haemoglobin mass of male endurance athletes sleeping at a simulated altitude of 3,000 m for 23 nights.
Eur J Appl Physiol
80:
479-484,
1999.
3.
Bisgard, GE,
and
Forster HV.
Ventilatory responses to acute and chronic hypoxia.
In: Handbook of Physiology. Environmental Physiology. Bethesda, MD: Am. Physiol. Soc, 1996, sect. 4, vol. II, chapt. 52, p. 1207-1239.
4.
Byrne-Quinn, E,
Weil JV,
Sodal IE,
Filley GF,
and
Grover RF.
Ventilatory control in the athlete.
J Appl Physiol
30:
91-98,
1971.
5.
Chapman, RF,
Stray-Gundersen J,
and
Levine BD.
Individual variation in response to altitude training.
J Appl Physiol
85:
1448-1456,
1998.
6.
Cunningham, DJC,
Robbins PA,
and
Wolff CB.
Integration of respiratory responses to changes in alveolar partial pressures of CO2 and O2 and in arterial pH.
In: Handbook of Physiology. The Respiratory System. Control of Breathing. Bethesda, MD: Am. Physiol. Soc, 1986, sect. 3, vol. II, pt. 2, chapt. 15, p. 475-528.
7.
Dempsey, JA,
and
Forster HV.
Mediation of ventilatory adaptations.
Physiol Rev
62:
262-346,
1982.
8.
Easton, PA,
Slykerman LJ,
and
Anthonisen NR.
Ventilatory response to sustained hypoxia in normal adults.
J Appl Physiol
61:
906-911,
1986.
9.
Fatemian, M,
Kim DY,
Poulin MJ,
and
Robbins PA.
Very mild exposure to hypoxia for 8 h can induce ventilatory acclimatization in humans.
Pflügers Arch
441:
840-843,
2001.
10.
Forster, HV,
Dempsey JA,
Birnbaum ML,
Reddan WG,
Thoden J,
Grover RF,
and
Rankin J.
Effect of chronic exposure to hypoxia on ventilatory response to CO2 and hypoxia.
J Appl Physiol
31:
586-592,
1971.
11.
Garcia, N,
Hopkins SR,
and
Powell FL.
Effects of intermittent hypoxia on the isocapnic hypoxic ventilatory response and erythropoiesis in humans.
Respir Physiol
123:
39-49,
2000.
12.
Gore, CJ.
Physiological Tests for Elite Athletes, edited by Gore CJ.. Champaign, IL: Human Kinetics, 2000, p. 6.
13.
Gore, CJ,
Crockett AJ,
Pederson DG,
Booth ML,
Bauman A,
and
Owen N.
Spirometric standards for healthy adult lifetime nonsmokers in Australia.
Eur Respir J
8:
773-782,
1995.
14.
Hahn, AG,
Gore CJ,
Martin DT,
Ashenden MJ,
Roberts AD,
and
Logan PA.
An evaluation of the concept of living at moderate altitude and training at sea level.
Comp Biochem Physiol A Mol Integr Physiol
128:
777-789,
2001.
15.
Harms, CA,
and
Stager JM.
Low chemoresponsiveness and inadequate hyperventilation contribute to exercise-induced hypoxemia.
J Appl Physiol
79:
575-580,
1995.
16.
Hirshman, CA,
McCullough RE,
and
Weil JV.
Normal values for hypoxic and hypercapnic ventilatory drives in man.
J Appl Physiol
38:
1095-1098,
1978.
17.
Hopkins, SR,
and
McKenzie DC.
Hypoxic ventilatory response and arterial desaturation during heavy work.
J Appl Physiol
67:
1119-1124,
1989.
18.
Hopkins, WG.
Measures of reliability in sports medicine and science.
Sports Med
30:
1-15,
2000.
19.
Huang, SY,
Alexander JK,
Grover RF,
Maher JT,
McCullough RE,
McCullough RG,
Moore LG,
Sampson JB,
Weil JV,
and
Reeves JT.
Hypocapnia and sustained hypoxia blunt ventilation on arrival at high altitude.
J Appl Physiol
56:
602-606,
1984.
20.
Huang, SY,
Alexander JK,
Grover RF,
Maher JT,
McCullough RE,
McCullough RG,
Moore LG,
Weil JV,
Sampson JB,
and
Reeves JT.
Increased metabolism contributes to increased resting ventilation at high altitude.
Respir Physiol
57:
377-385,
1984.
21.
Katayama, K,
Sato Y,
Ishida K,
Mori S,
and
Miyamura M.
The effects of intermittent exposure to hypoxia during endurance exercise training on the ventilatory responses to hypoxia and hypercapnia in humans.
Eur J Appl Physiol
78:
189-194,
1998.
22.
Katayama, K,
Sato Y,
Morotome Y,
Shima N,
Ishida K,
Mori S,
and
Miyamura M.
Ventilatory chemosensitive adaptations to intermittent hypoxic exposure with endurance training and detraining.
J Appl Physiol
86:
1805-1811,
1999.
23.
Katayama, K,
Sato Y,
Morotome Y,
Shima N,
Ishida K,
Mori S,
and
Miyamura M.
Cardiovascular response to hypoxia after endurance training at altitude and sea level and after detraining.
J Appl Physiol
88:
1221-1227,
2000.
24.
Katayama, K,
Sato Y,
Morotome Y,
Shima N,
Ishida K,
Mori S,
and
Miyamura M.
Intermittent hypoxia increases ventilation and SaO2 during hypoxic exercise and hypoxic chemosensitivity.
J Appl Physiol
90:
1431-1440,
2001.
25.
Levine, BD,
Friedman DB,
Engfred K,
Hanel B,
Kjaer M,
Clifford PS,
and
Secher NH.
The effect of normoxic or hypobaric hypoxic endurance training on the hypoxic ventilatory response.
Med Sci Sports Exerc
24:
769-775,
1992.
26.
Martin, BJ,
Weil JV,
Sparks KE,
McCullough RE,
and
Grover RF.
Exercise ventilation correlates positively with ventilatory chemoresponsiveness.
J Appl Physiol
45:
557-564,
1978.
27.
Moore, LG,
Cymerman A,
Huang SY,
McCullough RE,
McCullough RG,
Rock PB,
Young A,
Young P,
Weil JV,
and
Reeves JT.
Propranolol blocks metabolic rate increase but not ventilatory acclimatization to 4,300 m.
Respir Physiol
70:
195-204,
1987.
28.
Moore, LG,
Huang SY,
McCullough RE,
Sampson JB,
Maher JT,
Weil JV,
Grover RF,
Alexander JK,
and
Reeves JT.
Variable inhibition by falling CO2 of hypoxic ventilatory response in humans.
J Appl Physiol
56:
207-210,
1984.
29.
Reeves, JT,
McCullough RE,
Moore LG,
Cymerman A,
and
Weil JV.
Sea-level PCO2 relates to ventilatory acclimatization at 4,300 m.
J Appl Physiol
75:
1117-1122,
1993.
30.
Sahn, SA,
Zwillich CW,
Dick N,
McCullough RE,
Lakshminarayan S,
and
Weil JV.
Variability of ventilatory responses to hypoxia and hypercapnia.
J Appl Physiol
43:
1019-1025,
1977.
31.
Sato, M,
Severinghaus JW,
and
Bickler P.
Time course of augmentation and depression of hypoxic ventilatory responses at altitude.
J Appl Physiol
77:
313-316,
1994.
32.
Sato, M,
Severinghaus JW,
Powell FL,
Xu FD,
and
Spellman MJ.
Augmented hypoxic ventilatory response in men at altitude.
J Appl Physiol
73:
101-107,
1992.
33.
Schoene, RB,
Roach RC,
Hackett PH,
Sutton JR,
Cymerman A,
and
Houston CS.
Operation Everest II: ventilatory adaptation during gradual decompression to extreme altitude.
Med Sci Sports Exerc
22:
804-810,
1990.
34.
Scoggin, CH,
Doekel RD,
Kryger MH,
Zwillich CW,
and
Weil JV.
Familial aspects of decreased hypoxic drive in endurance athletes.
J Appl Physiol
44:
464-468,
1978.
35.
Van Klaveren, RJ,
and
Demedts M.
A mathematical and physiological evaluation of the different hypoxic response models in normal man.
Respir Physiol
113:
123-133,
1998.
36.
Velleman, PF,
and
Hoaglin DC.
Applications, Basics, and Computing of Exploratory Data Analysis. Boston, MA: Duxbury, 1981.
37.
Weil, JV,
Byrne-Quinn E,
Sodal IE,
Kline JS,
McCullough RE,
and
Filley GF.
Augmentation of chemosensitivity during mild exercise in normal man.
J Appl Physiol
33:
813-819,
1972.
38.
Weil, JV,
Byrne-Quinn E,
Sodal IE,
Friesen WO,
Underhill B,
Filley GF,
and
Grover RF.
Hypoxic ventilatory drive in normal man.
J Clin Invest
49:
1061-1072,
1970.
39.
White, DP,
Gleeson K,
Pickett CK,
Rannels AM,
Cymerman A,
and
Weil JV.
Altitude acclimatization: influence on periodic breathing and chemoresponsiveness during sleep.
J Appl Physiol
63:
401-412,
1987.
40.
Zhang, S,
and
Robbins PA.
Methodological and physiological variability within the ventilatory response to hypoxia in humans.
J Appl Physiol
88:
1924-1932,
2000.
This article has been cited by other articles:
![]() |
M. Hoshikawa, S. Uchida, T. Sugo, Y. Kumai, Y. Hanai, and T. Kawahara Changes in sleep quality of athletes under normobaric hypoxia equivalent to 2,000-m altitude: a polysomnographic study J Appl Physiol, December 1, 2007; 103(6): 2005 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Bavis, F. L. Powell, A. Bradford, C. C.W. Hsia, J. E. Peltonen, J. Soliz, B. Zeis, E. K. Fergusson, Z. Fu, M. Gassmann, et al. Respiratory plasticity in response to changes in oxygen supply and demand Integr. Comp. Biol., October 1, 2007; 47(4): 532 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Ainslie, A. Barach, K. J. Cummings, C. Murrell, M. Hamlin, and J. Hellemans Cardiorespiratory and cerebrovascular responses to acute poikilocapnic hypoxia following intermittent and continuous exposure to hypoxia in humans J Appl Physiol, May 1, 2007; 102(5): 1953 - 1961. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Basset, D. R. Joanisse, F. Boivin, J. St-Onge, F. Billaut, J. Dore, R. Chouinard, G. Falgairette, D. Richard, and M. R. Boulay Effects of short-term normobaric hypoxia on haematology, muscle phenotypes and physical performance in highly trained athletes Exp Physiol, March 1, 2006; 91(2): 391 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E Foster, D. C McKenzie, and A. W. Sheel Effects of enhanced human chemosensitivity on ventilatory responses to exercise Exp Physiol, January 1, 2006; 91(1): 221 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Clark, R. J. Aughey, C. J. Gore, A. G. Hahn, N. E. Townsend, T. A. Kinsman, C.-M. Chow, M. J. McKenna, and J. A. Hawley Effects of live high, train low hypoxic exposure on lactate metabolism in trained humans J Appl Physiol, February 1, 2004; 96(2): 517 - 525. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||